Pharmacology

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday9392
mod_vvisit_counterYesterday9043
mod_vvisit_counterThis week31274
mod_vvisit_counterLast week53012
mod_vvisit_counterThis month153085
mod_vvisit_counterLast month268832
mod_vvisit_counterAll days3656013

We have: 100 guests, 12 bots online
Your IP: 107.20.7.65
 , 
Today: Jun 19, 2013

JoomlaWatch Agent

Visitors hit counter, stats, email report, location on a map, SEO for Joomla, Wordpress, Drupal, Magento and Prestashop

JoomlaWatch Users

JoomlaWatch Visitors



57.1%United States United States
12.2%United Kingdom United Kingdom
5.6%Canada Canada
5.6%Australia Australia
3.4%Netherlands Netherlands
1.9%India India
1.5%Germany Germany
1.1%France France
1.1%Ireland Ireland
0.9%Philippines Philippines

Today: 264
Yesterday: 313
This Week: 921
Last Week: 2133
This Month: 5690
Last Month: 24906
Total: 51183


EMCDDA Report on the risks assessment of 4-MTA

Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs 1999

Title Filter     Display # 
# Article Title Author Hits
1 INTRODUCTION Richard Dennis 357
2 1. CHEMICAL DESCRIPTION Richard Dennis 470
3 2. PHARMACEUTICAL DESCRIPTION Richard Dennis 368
4 3. HEALTH RISKS Richard Dennis 349
5 4. SOCIAL RISKS: Sociological/criminological aspects Richard Dennis 441
6 5. POSSIBLE CONSEQUENCES OF PROHIBITION Richard Dennis 338
7 6. CONCLUSIONS Richard Dennis 497